Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

312.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 420.00
  • 52 Week Low: 210.00
  • Currency: UK Pounds
  • Shares Issued: 104.40m
  • Volume: 458
  • Market Cap: £325.71m

Maxcyte (DI) Overview

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners’ challenges by applying our expertise.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -117.0% -161.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 9.9 10.1
Pr/Book 1.8  
Latest F'cast
Revenue 415.8% -33.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 33.89 (19.08) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Jul-22 10.64 (6.43) (10.33)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 44.26 (23.57) (54.87)¢ n/a n/a n/a n/a 0.0%
31-Jul-23 8.00 (11.25) (11.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 41.29 (37.92) (37.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 34.22 (55.13) (39.93)p n/a n/a n/a n/a 0.0%
31-Dec-25 45.52 (47.86) (33.51)p n/a n/a n/a n/a 0.0%
31-Dec-26 65.90 (29.03) (32.13)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Notice of Results 10-Apr-2024 13:05 RNS
Total Voting Rights and Block Listing Return 03-Apr-2024 07:00 RNS
Signing of Strategic Platform License 02-Apr-2024 13:05 RNS

Maxcyte (DI) ShareCast News

MaxCyte reports strong fourth quarter as full-ye... 13-Mar-2024 ShareCast
MaxCyte flags lower 2023 revenue, flat 2024 growth 05-Mar-2024 ShareCast
MaxCyte flags uptick in total fourth-quarter rev... 09-Jan-2024 ShareCast

Latest Maxcyte (DI) Director Deals

Traded Action Notifier PriceAmountValue
26-Mar-24 Sell John Johnston 440.52p 5,000 £22,026.00
26-Mar-24 Exercise of option John Johnston 214.20p 5,000 £10,710.00
26-Feb-24 Sell John Johnston 364.62p 737 £2,687.26

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 312.00p
Change Today -1.00p
% Change -0.32 %
52 Week High 420.00
52 Week Low 210.00
Volume 458
Shares Issued 104.40m
Market Cap £325.71m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
12:32 450 @ 312.00p
08:06 8 @ 316.00p

Top of Page